← Leaderboards
William Blot
Vanderbilt University
$1,170,291
Attributed
$1,170,291
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $319.9K · FY2013–17$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,170,291 · 3
By mechanism
P50$1,170,291 · 3
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Jennifer A Pietenpol$43,416,854
- Gordon R. Bernard$207,867,283
- Raymond Nelson Dubois$22,706,669
- Alfred L George$44,065,377
- Roy A. Jensen$20,860,843
Others in their field
Top investigators on “High Prevalence”
- John M Lachin · George Washington University$125,907,614
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Gita Ramjee · Medical Research Council Of South Africa$89,161,330
- Taha E Taha · Johns Hopkins University$84,384,929
- Peter J O'Dwyer · University Of Pennsylvania$79,756,433
- Joseph B. Margolick · Johns Hopkins University$60,448,867
Research focus
High PrevalenceInflammatory MarkerEstrogen ReceptorsGonadal Steroid HormonesIncidenceInflammationAdiponectinEstradiolEstrogensGene Expression ProfileCancer RiskBiological MarkersAnabolismCase-Control StudiesCohortCohort StudiesCommunitiesEpidemiologic StudiesComplexBreastBreast Cancer PreventionEstroneDiagnosticInstruction
Grant awards (6)
The obesity-metabolic biomarker axis and breast cancer risk$192,749
P50 · FY2017 · CA · contact PI
The obesity-metabolic biomarker axis and breast cancer risk$192,269
P50 · FY2016 · CA · contact PI
The obesity-metabolic biomarker axis and breast cancer risk$209,903
P50 · FY2015 · CA · contact PI
The obesity-metabolic biomarker axis and breast cancer risk$101,898
P50 · FY2015 · CA · contact PI
The obesity-metabolic biomarker axis and breast cancer risk$319,864
P50 · FY2014 · CA · contact PI
The obesity-metabolic biomarker axis and breast cancer risk$153,608
P50 · FY2013 · CA · contact PI